Novozymes A/S - SIC # 3080 -

Ticker Exchange SIC # Website Latest Ticker
NVZMY Over the counter 3080 www.novonesis.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Novozymes A/S

9M 2026: Novonesis delivered 7% organic sales growth, confirming full-year outlook - Nov 5th, 2026 12:10 am
Interim report 9M 2026 - Nov 4th, 2026 11:58 pm
Novozymes (CPSE:NSIS B) Stock Looks Reasonable After Its 64% Run - Oct 25th, 2026 6:22 pm
Novonesis Opens Doors to Students to Inspire the Next Generation of U.S. Biomanufacturing Talent - Oct 15th, 2026 6:56 am
Novonesis completes acquisition of MicroBioGen, strengthening its yeast capabilities - Oct 1st, 2026 7:11 am
Novonesis celebrates major expansion of West Allis production facility, strengthening North American dairy innovation and manufacturing - Sep 28th, 2026 7:35 am
Novozymes (CPSE:NSIS B) Could Be 13% Undervalued After €600 Million Patalganga Expansion - Sep 14th, 2026 11:13 am
Initiation of Novonesis’ share buyback program - Sep 14th, 2026 1:08 am
Novonesis to build next generation enzyme production facility in India - Sep 2nd, 2026 1:38 am
Novonesis (Novozymes) B's Dividend Analysis - Aug 31st, 2026 5:04 am
Novonesis Expands U.S. Workforce Development Efforts to Build the Next Generation of Biomanufacturing Talent - Aug 26th, 2026 6:00 am
FUL or NVZMY: Which Is the Better Value Stock Right Now? - Aug 24th, 2026 9:40 am
Novonesis (Novozymes) B (NVZMF) (H1 2026) Earnings Call Highlights: Raises Guidance on 8% ... - Aug 20th, 2026 9:02 am
H1 2026: Novonesis delivered strong 8% organic sales growth and increases full-year outlook - Aug 19th, 2026 10:26 am
Interim report H1 2026 - Aug 19th, 2026 9:42 am
Announcement of share buyback program - Aug 19th, 2026 9:41 am
Novonesis launches Optiva® Triticum to help pasta manufacturers navigate wheat volatility without compromising quality - Aug 12th, 2026 5:12 am
[Latest] Global Microbial Biostimulants Market Size/Share Worth USD 13.88 Billion by 2034 at a 10.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - Aug 12th, 2026 1:30 am
Novonesis to acquire remaining share of MicroBioGen to strengthen yeast capabilities - Aug 10th, 2026 1:24 am
FUL vs. NVZMY: Which Stock Is the Better Value Option? - Aug 7th, 2026 9:40 am